Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study
- PMID: 30953181
- DOI: 10.1007/s00392-019-01473-3
Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study
Abstract
Background: Impact of body mass index (BMI) on all-cause mortality in atrial fibrillation (AF) patients remains controversial.
Methods: A total of 10,942 AF patients were prospectively enrolled and categorized into four BMI groups: underweight (BMI < 18.5 kg/m2), normal weight (BMI 18.5-24 kg/m2), overweight (BMI 24-28 kg/m2) and obesity (BMI ≥ 28 kg/m2). The primary outcome was all-cause mortality. Different Cox proportional hazards models were performed to evaluate the association between BMI and all-cause mortality.
Results: During a median follow-up of 30 months (IQR 18-48 months), 862 deaths events occurred. Compared to normal BMI, higher BMI was associated with a lower mortality risk (overweight: HR 0.70; 95% CI 0.61-0.81, P < 0.0001 and obesity: HR 0.54; 95% CI 0.44-0.67, P < 0.0001) and lower BMI was associated with a higher mortality risk (HR 2.23, 95% CI 1.67-2.97, P < 0.0001).
Conclusion: A reversed relationship between BMI and all-cause mortality in AF patients was found. Higher risk of mortality was observed in underweight patients compared to patients with a normal BMI, while overweight and obese patients had a lower risk of all-cause mortality.
Clinical trial registration: URL: http://www.chictr.org.cn/showproj.aspx?proj=5831. Unique identifier: ChiCTR-OCH-13003729.
Keywords: All-cause mortality; Arial fibrillation; Body mass index.
Similar articles
-
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox.Clin Cardiol. 2021 May;44(5):599-608. doi: 10.1002/clc.23593. Epub 2021 Mar 26. Clin Cardiol. 2021. PMID: 33769583 Free PMC article.
-
BMI differences among in-hospital management and outcomes in patients with atrial fibrillation: findings from the Care for Cardiovascular Disease project in China.BMC Cardiovasc Disord. 2020 Jun 5;20(1):270. doi: 10.1186/s12872-020-01544-8. BMC Cardiovasc Disord. 2020. PMID: 32503432 Free PMC article.
-
Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2242-2251. doi: 10.1016/j.numecd.2020.07.028. Epub 2020 Jul 28. Nutr Metab Cardiovasc Dis. 2020. PMID: 32900569
-
Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.Clin Res Cardiol. 2014 Jul;103(7):533-42. doi: 10.1007/s00392-014-0681-7. Epub 2014 Feb 18. Clin Res Cardiol. 2014. PMID: 24535378
-
A U-shaped association of body mass index and all-cause mortality in heart failure patients: A dose-response meta-analysis of prospective cohort studies.Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12232. Cardiovasc Ther. 2017. PMID: 27783461 Review.
Cited by
-
Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID-19.Obesity (Silver Spring). 2020 Nov;28(11):2049-2055. doi: 10.1002/oby.22979. Epub 2020 Sep 23. Obesity (Silver Spring). 2020. PMID: 32735706 Free PMC article.
-
Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial.Front Pharmacol. 2022 Jun 3;13:755536. doi: 10.3389/fphar.2022.755536. eCollection 2022. Front Pharmacol. 2022. PMID: 35721170 Free PMC article.
-
Prognostic Impact of Body Mass Index in Atrial Fibrillation.J Clin Med. 2024 Jun 3;13(11):3294. doi: 10.3390/jcm13113294. J Clin Med. 2024. PMID: 38893005 Free PMC article.
-
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox.Clin Cardiol. 2021 May;44(5):599-608. doi: 10.1002/clc.23593. Epub 2021 Mar 26. Clin Cardiol. 2021. PMID: 33769583 Free PMC article.
-
Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation.Heart Vessels. 2020 Aug;35(8):1125-1134. doi: 10.1007/s00380-020-01587-z. Epub 2020 Apr 6. Heart Vessels. 2020. PMID: 32253531 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- 2016YFC0900901/National Key Research and Development Program of China
- 2016YFC1301002/National Key Research and Development Program of China
- 81530016/National Science Foundation of China
- D151100002215003/Beijing Municipal Commission of Science and Technology
- D151100002215004/Beijing Municipal Commission of Science and Technology
LinkOut - more resources
Full Text Sources
Medical